Universal Ibogaine Provides Corporate Update

(TheNewswire)

Calgary, AB – TheNewswire - October 28, 2025 – Universal Ibogaine Inc.( TSXV:IBO ) (“ UI ” or the “ Company ”), a life sciences company with amission to research and deliver medicalized ibogaine-centeredaddiction care, advises that effective October 24, 2025, the Companyhas temporarily closed its Kelburn Recovery Centre (“ Kelburn ”)operation.  Kelburn is located south-east of Winnipeg, Manitoba, andhas operated to provide addiction treatment and mental health carecounselling services.

UI is in process of undertaking a re-structuring,including pursuing various financing options, which may include theultimate sale of or leasing of the Kelburn property to a third party. As part of this process, Kelburn has been closed, and its staff laidoff.  UI continues to focus on its  main business, which is theeffort to have Ibogaine approved for use under UI’s Clinical TrialApplication which is planned to be submitted to Health Canada.

About UniversalIbogaine Inc.

UI is a life sciences company, with a mission totransform addiction treatment using medicalized ibogaine through aplanned Canadian clinical trial focused on opioid use disorder, andultimately to utilize that treatment protocol globally through plannedfuture licensing agreements. UI’s goal is to revolutionize the way we treat addictionand drastically improve the lives of individuals and families affectedby addiction.

NEITHER THE TSXVENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM ISDEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTSRESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THISRELEASE.

CAUTIONARY STATEMENTREGARDING FORWARD-LOOKING STATEMENTS

?This news release may containforward-looking statements and information. Forward-lookinginformation is frequently characterized by words such ?as"plans", “planned”, "expect","project", "intends", “intended”"will", "believe", "anticipate","estimate", "scheduled",??"potential", or other similar words, or statementsthat certain events or conditions "may", "should"or ??"could" occur.  The forward-looking statements andinformation are based on certain key expectations ?and assumptionsmade by UI at the date the statements are made.  Although UI believesthat the expectations and assumptions on which the forward-?lookingstatements are based are reasonable, undue reliance should not beplaced on the forward-?looking statements because UI can give noassurance that they will prove to be correct.

Since ?forward-looking statementsaddress future events and conditions, by their very nature theyinvolve ?inherent risks and uncertainties. Actual results coulddiffer materially from those currently anticipated ?due to a numberof factors and risks, which include, but are not limited to, risksthat required ?regulatory approvals are not obtained. The reader iscautioned that assumptions used in the ?preparation of suchinformation, although considered reasonable by UI at the time of?preparation, may prove to be incorrect and readers are cautionednot to place undue reliance on ?forward-looking information, whichspeaks only to conditions as of the date hereof.  UI does not?undertake any obligation to release publicly any revisions toforward-looking information contained ?herein to reflect events orcircumstances that occur after the date hereof or to reflect theoccurrence ?of unanticipated events, except as may be required underapplicable securities laws. ?

Additional information identifying risks anduncertainties that could affect financial results and the Company iscontained in the Company’s filings with Canadian securitiesregulators, which are available at www.sedar.com

For furtherinformation:

Nick Karos, CEO

Universal Ibogaine Inc.

612-309-3527

Nick.Karos@universalibogaine.com

Related Links

https://universalibogaine.com

Copyright (c) 2025 TheNewswire - All rights reserved.